Stryker Corporation (SYK) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Stryker Corporation (SYK) Bundle
Looking to assess the intrinsic value of Stryker Corporation? Our SYK DCF Calculator integrates real-world data with extensive customization features, allowing you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,884.0 | 14,351.0 | 17,108.0 | 18,449.0 | 20,498.0 | 22,269.8 | 24,194.7 | 26,286.1 | 28,558.2 | 31,026.6 |
| Revenue Growth, % | 0 | -3.58 | 19.21 | 7.84 | 11.11 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 |
| EBITDA | 4,176.0 | 3,755.0 | 4,646.0 | 4,536.0 | 4,934.0 | 5,791.8 | 6,292.4 | 6,836.3 | 7,427.2 | 8,069.2 |
| EBITDA, % | 28.06 | 26.17 | 27.16 | 24.59 | 24.07 | 26.01 | 26.01 | 26.01 | 26.01 | 26.01 |
| Depreciation | 778.0 | 812.0 | 990.0 | 998.0 | 1,028.0 | 1,206.9 | 1,311.2 | 1,424.5 | 1,547.7 | 1,681.4 |
| Depreciation, % | 5.23 | 5.66 | 5.79 | 5.41 | 5.02 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
| EBIT | 3,398.0 | 2,943.0 | 3,656.0 | 3,538.0 | 3,906.0 | 4,584.9 | 4,981.2 | 5,411.8 | 5,879.6 | 6,387.8 |
| EBIT, % | 22.83 | 20.51 | 21.37 | 19.18 | 19.06 | 20.59 | 20.59 | 20.59 | 20.59 | 20.59 |
| Total Cash | 4,425.0 | 3,024.0 | 3,019.0 | 1,928.0 | 3,053.0 | 4,177.5 | 4,538.6 | 4,930.9 | 5,357.1 | 5,820.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,893.0 | 2,701.0 | 3,022.0 | 3,565.0 | 3,765.0 | 4,169.5 | 4,529.9 | 4,921.5 | 5,346.9 | 5,809.0 |
| Account Receivables, % | 19.44 | 18.82 | 17.66 | 19.32 | 18.37 | 18.72 | 18.72 | 18.72 | 18.72 | 18.72 |
| Inventories | 3,282.0 | 3,494.0 | 3,314.0 | 3,995.0 | 4,843.0 | 4,946.1 | 5,373.6 | 5,838.1 | 6,342.7 | 6,891.0 |
| Inventories, % | 22.05 | 24.35 | 19.37 | 21.65 | 23.63 | 22.21 | 22.21 | 22.21 | 22.21 | 22.21 |
| Accounts Payable | 675.0 | 810.0 | 1,129.0 | 1,413.0 | 1,517.0 | 1,418.1 | 1,540.6 | 1,673.8 | 1,818.5 | 1,975.7 |
| Accounts Payable, % | 4.54 | 5.64 | 6.6 | 7.66 | 7.4 | 6.37 | 6.37 | 6.37 | 6.37 | 6.37 |
| Capital Expenditure | -649.0 | -487.0 | -525.0 | -588.0 | -575.0 | -748.9 | -813.7 | -884.0 | -960.4 | -1,043.4 |
| Capital Expenditure, % | -4.36 | -3.39 | -3.07 | -3.19 | -2.81 | -3.36 | -3.36 | -3.36 | -3.36 | -3.36 |
| Tax Rate, % | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 |
| EBITAT | 2,762.7 | 2,408.3 | 3,196.0 | 3,109.4 | 3,365.8 | 3,893.6 | 4,230.1 | 4,595.8 | 4,993.0 | 5,424.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,608.3 | 2,848.3 | 3,839.0 | 2,579.4 | 2,874.8 | 3,745.0 | 4,062.3 | 4,413.4 | 4,794.9 | 5,209.4 |
| WACC, % | 8.36 | 8.36 | 8.38 | 8.38 | 8.37 | 8.37 | 8.37 | 8.37 | 8.37 | 8.37 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 17,344.9 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 5,418 | |||||||||
| Terminal Value | 124,006 | |||||||||
| Present Terminal Value | 82,969 | |||||||||
| Enterprise Value | 100,314 | |||||||||
| Net Debt | 10,024 | |||||||||
| Equity Value | 90,290 | |||||||||
| Diluted Shares Outstanding, MM | 384 | |||||||||
| Equity Value Per Share | 235.32 |
What You Will Get
- Editable Forecast Inputs: Easily adjust assumptions (growth %, margins, WACC) to generate various scenarios.
- Real-World Data: Stryker Corporation’s (SYK) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that tailors to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- Customizable Financial Inputs: Adjust essential factors such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and various outputs in real-time.
- High-Precision Accuracy: Leverages Stryker Corporation’s (SYK) actual financial data for dependable valuation results.
- Simplified Scenario Analysis: Effortlessly evaluate different assumptions and analyze results side-by-side.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Stryker Corporation (SYK) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Stryker Corporation (SYK)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Stryker Corporation (SYK)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses all in one convenient package.
- Customizable Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Stryker’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Stryker Corporation (SYK).
Who Should Use This Product?
- Healthcare Professionals: Understand the financial metrics that drive companies like Stryker Corporation (SYK).
- Researchers: Utilize advanced models to analyze trends in the medical device industry.
- Investors: Evaluate your investment strategies and assess the valuation of Stryker Corporation (SYK).
- Financial Analysts: Enhance your analysis with a customizable DCF model specifically for Stryker Corporation (SYK).
- Business Students: Explore how major players like Stryker Corporation (SYK) are valued in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Stryker Corporation (SYK) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Stryker Corporation (SYK).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.